An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients

Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea

NCT01018160 ·Status: COMPLETED

Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis

NCT04022096 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease

NCT01400945 ·Status: COMPLETED ·Phase: PHASE3

The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.

NCT00171457 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)

NCT00216489 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease

NCT02556021 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Treatment Outcome and Cost-effectiveness for GERD

NCT03661151 ·Status: UNKNOWN

Retrospective Observational Study on GERD Management in General Hospitals in Korea

NCT06974903 ·Status: COMPLETED

The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD

NCT00539786 ·Status: UNKNOWN ·Phase: NA

Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.

NCT04001400 ·Status: COMPLETED ·Phase: PHASE3

Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients

NCT00768196 ·Status: COMPLETED

A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients

NCT00787891 ·Status: COMPLETED ·Phase: PHASE3

Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)

NCT00222170 ·Status: COMPLETED ·Phase: PHASE2

Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"

NCT03214081 ·Status: COMPLETED

Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux Symptoms

NCT07707011 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)

NCT00911534 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

NCT00171483 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial

NCT01888549 ·Status: COMPLETED ·Phase: NA

A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)

NCT00149851 ·Status: COMPLETED ·Phase: PHASE2

Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions

NCT00612027 ·Status: COMPLETED

Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

NCT00171418 ·Status: COMPLETED ·Phase: PHASE3

Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease

NCT02114216 ·Status: COMPLETED ·Phase: NA

Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

NCT01321567 ·Status: COMPLETED

Adipokines and the Risk of Reflux Esophagitis

NCT01560598 ·Status: UNKNOWN

Lesogaberan in Chinese Patients With Refractory Reflux Symptoms

NCT02818309 ·Status: UNKNOWN ·Phase: PHASE2